N4 Pharma Plc (LON:N4P – Get Free Report)’s share price reached a new 52-week low during trading on Thursday . The company traded as low as GBX 0.60 ($0.01) and last traded at GBX 0.65 ($0.01), with a volume of 3405743 shares traded. The stock had previously closed at GBX 0.75 ($0.01).
N4 Pharma Trading Up 14.4 %
The firm has a 50-day moving average of GBX 0.75 and a two-hundred day moving average of GBX 0.81. The firm has a market capitalization of £1.92 million, a P/E ratio of -71.50 and a beta of -0.07. The company has a current ratio of 14.86, a quick ratio of 7.28 and a debt-to-equity ratio of 1.62.
N4 Pharma Company Profile
N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
See Also
- Five stocks we like better than N4 Pharma
- How to Find Undervalued Stocks
- MarketBeat Week in Review – 5/20 – 5/24
- Why Invest in Biotech Stocks
- NASDAQ 100 vs. NASDAQ Composite: A Detailed Breakdown of NASDAQ
- Insider Trades May Not Tell You What You Think
- These 2 Retail Traders Favorites are Nearing Major Breakouts
Receive News & Ratings for N4 Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for N4 Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
